+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Formulation and characterization of hydrophilic drug diclofenac sodium-loaded solid lipid nanoparticles based on phospholipid complexes technology



Formulation and characterization of hydrophilic drug diclofenac sodium-loaded solid lipid nanoparticles based on phospholipid complexes technology



Journal of Liposome Research 24(1): 17-26



To successfully prepare the diclofenac sodium (DS)-loaded solid lipid nanoparticles (SLNs), phospholipid complexes (PCs) technology was applied here to improve the liposolubility of DS. Solid lipid nanoparticles (SLNs) loaded with phospholipid complexes (PCs) were prepared by the modified emulsion/solvent evaporation method. DS could be solubilized effectively in the organic solvents with the existence of phospholipid and apparent partition coefficient of DS in PCs increased significantly. X-ray diffraction analysis suggested that DS in PCs was either molecularly dispersed or in an amorphous form. However, no significant difference was observed between the Fourier transform infrared spectroscopy (FT-IR) spectra of physical mixture and that of PCs. Particles with small sizes, narrow polydispersity indexes and high entrapment efficiencies could be obtained with the addition of PCs. Furthermore, according to the transmission electron microscopy, a core-shell structure was likely to be formed. The presence of PCs caused the change of zeta potential and retarded the drug release of SLNs, which indicated that phospholipid formed multilayers around the solid lipid core of SLNs. Both FT-IR and differential scanning calorimetry analysis also illustrated that some weak interactions between DS and lipid materials might take place during the preparation of SLNs. In conclusion, the model hydrophilic drug-DS can be formulated into the SLNs with the help of PCs.

(PDF emailed within 0-6 h: $19.90)

Accession: 053287923

Download citation: RISBibTeXText

PMID: 24236407

DOI: 10.3109/08982104.2013.826241


Related references

Formulation, characterization and cytotoxicity studies of alendronate sodium-loaded solid lipid nanoparticles. Colloids and Surfaces. B, Biointerfaces 117: 21-28, 2014

Formulation and physicochemical characterization of poly(epsilon-caprolactone) nanoparticles loaded with ftorafur and diclofenac sodium. Colloids and Surfaces. B, Biointerfaces 75(1): 204-208, 2010

Diclofenac sodium-loaded solid lipid nanoparticles prepared by emulsion/solvent evaporation method. Journal of Nanoparticle Research 13(6): 2375-2386, 2011

Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. I. Effect of formulation variables on the physicochemical properties, drug release and stability of clotrimazole-loaded nanoparticles. Nanotechnology 25(10): 105101, 2014

Formulation and in vitro characterization of domperidone loaded solid lipid nanoparticles and nanostructured lipid carriers. Daru 19(1): 23-32, 2011

Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization. International Journal of Pharmaceutics 340(1-2): 153-162, 2007

Formulation and characterization of curcuminoids loaded solid lipid nanoparticles. International Journal of Pharmaceutics 337(1-2): 299-306, 2007

Formulation and Physicochemical Characterization of Lycopene-Loaded Solid Lipid Nanoparticles. Advanced Pharmaceutical Bulletin 6(2): 235-241, 2016

Development of dry powder inhaler formulation loaded with alendronate solid lipid nanoparticles: solid-state characterization and aerosol dispersion performance. Drug Development and Industrial Pharmacy 41(9): 1431-1437, 2016

Cyclosporine a loaded solid lipid nanoparticles: optimization of formulation, process variable and characterization. Current Drug Delivery 5(1): 64-69, 2008

Formulation, optimization, and characterization of rifampicin-loaded solid lipid nanoparticles for the treatment of tuberculosis. Drug Development and Industrial Pharmacy 44(12): 1975-1989, 2018

Formulation, characterization, and in vitro/vivo studies of aclacinomycin A-loaded solid lipid nanoparticles. Drug Delivery 23(4): 1317-1325, 2017

Formulation, characterization and pharmacokinetics of praziquantel-loaded hydrogenated castor oil solid lipid nanoparticles. Nanomedicine 5(5): 693-701, 2010

Cyclosporine-loaded solid lipid nanoparticles (SLN): drug-lipid physicochemical interactions and characterization of drug incorporation. European Journal of Pharmaceutics and Biopharmaceutics 68(3): 535-544, 2007

Effects of Formulation Variables on the Particle Size and Drug Encapsulation of Imatinib-Loaded Solid Lipid Nanoparticles. Aaps Pharmscitech 17(3): 652-662, 2017